ABVC BIOPHARMA, INC. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Abvc Biopharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Abvc Biopharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $49.9K.
  • Abvc Biopharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$6.33M, a 32.5% increase year-over-year.
  • Abvc Biopharma, Inc. annual Operating Income (Loss) for 2023 was -$8.22M, a 45.6% increase from 2022.
  • Abvc Biopharma, Inc. annual Operating Income (Loss) for 2022 was -$15.1M, a 29.1% decline from 2021.
  • Abvc Biopharma, Inc. annual Operating Income (Loss) for 2021 was -$11.7M, a 37.6% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$6.33M $49.9K +$2.2M Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$8.54M -$977K +$1.22M +55.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 -$9.75M -$3.44M -$1.54M -80.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-17
Q4 2023 -$8.22M -$1.96M +$1.17M +37.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-13
Q3 2023 -$9.39M -$2.15M +$1.56M +42% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$10.9M -$2.19M -$147K -7.18% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 -$10.8M -$1.91M +$4.31M +69.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-17
Q4 2022 -$15.1M -$3.13M +$3.31M +51.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-13
Q3 2022 -$18.4M -$3.72M -$1.75M -88.6% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-15
Q2 2022 -$16.7M -$2.05M -$11.3K -0.56% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$16.7M -$6.22M -$4.97M -396% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$11.7M -$6.45M -$1.6M -32.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$10.1M -$1.97M -$681K -52.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$9.43M -$2.04M -$842K -70.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$8.59M -$1.25M -$81.4K -6.95% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$8.51M -$4.85M -$3.73M -332% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$4.78M -$1.29M -$174K -15.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$4.6M -$1.19M -$705K -144% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$3.9M -$1.17M -$441K -60.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 -$3.46M -$1.12M +$65.9K +5.54% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 -$3.52M -$1.12M -$719K -182% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-17
Q2 2019 -$2.81M -$489K +$35.6K +6.79% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$2.84M -$731K -$56.4K -8.36% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-30
Q4 2018 -$2.78M -$1.19M -$837K -237% Oct 1, 2018 Dec 31, 2018 10-K 2020-05-15
Q3 2018 -$1.95M -$396K +$2.96M +88.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-18
Q2 2018 -$4.91M -$524K -$335K -177% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$4.58M -$674K -$437K -185% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-28
Q4 2017 -$4.14M -$353K -$142K -67.7% Oct 1, 2017 Dec 31, 2017 10-KT 2018-04-13
Q3 2017 -$4M -$3.36M -$2.76M -462% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$1.23M -$189K +$99.6K +34.5% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-20
Q1 2017 -$1.33M -$237K +$6.37M +96.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$7.71M -$210K +$3.29M +94% Oct 1, 2016 Dec 31, 2016 10-KT 2018-04-13
Q3 2016 -$11M -$598K -$282K -89.4% Jul 1, 2016 Sep 30, 2016 10-KT 2018-04-13
Q2 2016 -$10.7M -$289K -$288K Apr 1, 2016 Jun 30, 2016 10-Q/A 2018-03-19
Q1 2016 -$10.4M -$6.61M -$6.61M Jan 1, 2016 Mar 31, 2016 10-Q/A 2018-03-19
Q4 2015 -$3.82M -$3.5M -$2.47M -240% Oct 1, 2015 Dec 31, 2015 10-Q/A 2018-03-19
Q3 2015 -$1.35M -$316K Jul 21, 2015 Sep 30, 2015 10-Q/A 2017-02-22
Q2 2015 -$1.5K* -$1.47K Apr 1, 2015 Jun 30, 2015 10-Q 2015-08-19
Q1 2015 $1.12K* +$1.15K Jan 1, 2015 Mar 31, 2015 10-Q/A 2015-06-05
Q4 2014 -$1.03M -$1.03M Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-23
Q2 2014 -$70 -$30* +$19.3K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-19
Q1 2014 -$19.4K -$30* +$20.4K Jan 1, 2014 Mar 31, 2014 10-Q/A 2015-06-05
Q4 2013 -$39.8K -$10* +$137K Oct 1, 2013 Dec 31, 2013 10-Q 2015-04-17
Q3 2013 -$177K $0 +$108K Jul 1, 2013 Sep 30, 2013 10-K 2015-04-16
Q2 2013 -$285K -$19.4K +$226K +92.1% Apr 1, 2013 Jun 30, 2013 10-Q 2015-04-17
Q1 2013 -$511K -$20.5K +$310K +93.8% Jan 1, 2013 Mar 31, 2013 10-Q 2015-04-17
Q4 2012 -$822K -$137K +$322K +70.1% Oct 1, 2012 Dec 31, 2012 10-Q 2015-04-17
Q3 2012 -$1.14M -$108K +$310K +74.1% Jul 1, 2012 Sep 30, 2012 10-K 2015-04-16
Q2 2012 -$1.45M -$245K +$528K +68.3% Apr 1, 2012 Jun 30, 2012 10-Q 2015-04-16
Q1 2012 -$1.98M -$331K -$1.84K -0.56% Jan 1, 2012 Mar 31, 2012 10-Q 2015-04-16
Q4 2011 -$1.98M -$459K -$90.8K -24.7% Oct 1, 2011 Dec 31, 2011 10-Q 2015-04-16
Q3 2011 -$1.89M -$418K Jul 1, 2011 Sep 30, 2011 10-K 2015-04-15
Q2 2011 -$773K -$434K -128% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-08-20
Q1 2011 -$329K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-15
Q4 2010 -$368K Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-21
Q2 2010 -$339K Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-09-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.